Show simple item record

Deletions in the NF-kB pathway as drivers of resistance in Multiple Myeloma. Deletions of BIRC2, BIRC3, CYLD and TRAF3 and their role in relapse.

dc.rights.licenseCC-BY-NC-ND
dc.contributor.advisorSantos Oliveira, S.
dc.contributor.authorJansen, Jacqueline
dc.date.accessioned2023-06-29T23:01:08Z
dc.date.available2023-06-29T23:01:08Z
dc.date.issued2023
dc.identifier.urihttps://studenttheses.uu.nl/handle/20.500.12932/44050
dc.description.sponsorshipUtrecht University
dc.language.isoEN
dc.subjectThe report is about how deletion of BIRC2, BIRC3, CYLD and TRAF3, players in the NF-kB pathway contribute to resistance to pomalidomide and dexamethasone in Multiple Myeloma Cell lines.
dc.titleDeletions in the NF-kB pathway as drivers of resistance in Multiple Myeloma. Deletions of BIRC2, BIRC3, CYLD and TRAF3 and their role in relapse.
dc.type.contentMaster Thesis
dc.rights.accessrightsOpen Access
dc.subject.keywordsMultiple Myeloma, BIRC2, BIRC3, CYLD, TRAF3, resistance, pomalidomide, dexamethasone
dc.subject.courseuuMolecular and Cellular Life Sciences
dc.thesis.id5152


Files in this item

Thumbnail
Name:
Eindwerk MM_final version.pdf
Size:
34.06Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record